Frontiers in Pharmacology

A new era in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): clinical breakthroughs and challenges

By Zhifu You, Linglong Yang, Yuanhao Long, Dongye You, Qian Zhao

ReviewInterventions

The paper

Zhifu You, Linglong Yang, Yuanhao Long, Dongye You, Qian Zhao

First Affiliated Hospital of Heilongjiang University of Chinese Medicine; South Hospital of Qiqihar Traditional Chinese Medicine Hospital

Frontiers in Pharmacology, 31 Aug 2026

doi.org/10.3389/fphar.2026.1815576 PubMed 42741482

Nature Metabolism2 Oct 2026
Dasatinib and quercetin reduce liver fibrosis in a phase-2 MASH trial
Frontiers in Nutrition4 Oct 2026
Cardiometabolic burden is linked to CVD and death in MASLD
Frontiers in Nutrition9 Oct 2026
Moderate tea drinking linked to lower death risk in MASLD
Hepatology International7 Oct 2026
Blood proteins linked aging measures to fatty liver disease risk